Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
CPhI North America
Preview of Day 3:
Thursday, May 2, 2019
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

Welcome to your inside look into the last day of CPhI North America 2019. See www.cphinorthamerica.com for more details.

Don’t forget to visit Pharmaceutical Technology at Booth 2446!


 

HIGHLIGHTS

Women in Leadership Forum Set for CPhI North America 2019

Thursday, May 2, 8:00am–11:00am

The program and speakers for CPhI North America's third Women in Leadership Forum have been announced, happening on Thursday, May 2 from 8:00am–11:00am in Chicago, IL.
/ Read more /


CPhI North America Partners with iBIO to Foster Female Leadership in Biopharma

The partnership includes a $10,000 donation to fund Illinois Biotechnology Innovation Organization (iBIO) STEM programming for girls in grades three through eight.
/ Read more /

McCormick Place, Chicago, IL


Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe

SCHEDULE OF EVENTS FOR MAY 2

Exhibits

Wednesday, May 1, 10:00am–3:00pm

Conference Sessions

Wednesday, May 1, 9:00am–12:30pm

 

NEWS

Sharp to Expand US Packaging Capacity and Capabilities

Contract packaging and clinical supply service company Sharp invested $21 million to expand its packaging capacity and capabilities in Pennsylvania.
/ Read more /


Catalent Invests $40 Million at Kentucky Manufacturing Facility

The investment will increase patient-centric dosage form manufacturing capabilities at Catalent’s Winchester, KY, facility.
/ Read more /


Sterling Pharma Solutions Receives Queen’s Award for International Trade

Sterling Pharma Solutions has been granted a Queen’s Award for Enterprise in the field of International Trade.
/ Read more /


Alcami’s St. Louis Facility Issued European Medicines Agency Certification

The company’s center of excellence for advanced analytical testing passed GMP inspection from the European Medicines Agency.
/ Read more /


Regis Passes 2019 FDA Inspection

Regis Technologies reported that no Form 483 observations were issued following a routine FDA inspection.
/ Read more /


Integrated First-in-Human Service Package for Poorly Soluble Small Molecules

Lonza’s SimpliFiH Services addresses bioavailability challenges with drug substance, solid-state characterization, and drug product for first-in-human studies.
/ Read more /


contribute | contact editors | CONTACT SALES | subscribe | advertise